Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| enterocyte | 7 studies | 47% ± 16% | |
| epithelial cell | 7 studies | 38% ± 19% | |
| goblet cell | 6 studies | 42% ± 11% | |
| epithelial cell of proximal tubule | 5 studies | 46% ± 23% | |
| intestinal crypt stem cell | 3 studies | 53% ± 6% | |
| progenitor cell | 3 studies | 39% ± 14% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| intestine | 5 studies | 29% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 95% | 1150.67 | 310 / 328 | 65% | 20.50 | 115 / 178 |
| thymus | 99% | 1765.02 | 649 / 653 | 50% | 124.39 | 303 / 605 |
| prostate | 65% | 309.56 | 159 / 245 | 83% | 15.67 | 417 / 502 |
| liver | 96% | 6803.57 | 218 / 226 | 45% | 76.78 | 182 / 406 |
| stomach | 74% | 590.26 | 266 / 359 | 64% | 15.73 | 184 / 286 |
| kidney | 100% | 7646.70 | 89 / 89 | 25% | 17.88 | 227 / 901 |
| intestine | 35% | 267.15 | 342 / 966 | 70% | 17.51 | 370 / 527 |
| brain | 52% | 164.15 | 1362 / 2642 | 30% | 3.35 | 214 / 705 |
| ovary | 0% | 0 | 0 / 180 | 78% | 55.72 | 337 / 430 |
| esophagus | 26% | 214.87 | 373 / 1445 | 52% | 15.98 | 95 / 183 |
| lymph node | 0% | 0 | 0 / 0 | 62% | 118.16 | 18 / 29 |
| skin | 40% | 50.89 | 725 / 1809 | 16% | 2.25 | 77 / 472 |
| uterus | 1% | 4.02 | 2 / 170 | 51% | 6.91 | 233 / 459 |
| lung | 14% | 17.46 | 79 / 578 | 38% | 5.59 | 440 / 1155 |
| tonsil | 0% | 0 | 0 / 0 | 44% | 6.03 | 20 / 45 |
| bladder | 0% | 0 | 0 / 21 | 41% | 8.40 | 205 / 504 |
| adipose | 21% | 63.92 | 256 / 1204 | 0% | 0 | 0 / 0 |
| breast | 3% | 4.79 | 14 / 459 | 10% | 2.41 | 107 / 1118 |
| peripheral blood | 9% | 42.63 | 85 / 929 | 0% | 0 | 0 / 0 |
| adrenal gland | 0% | 0.25 | 1 / 258 | 5% | 2.30 | 12 / 230 |
| blood vessel | 2% | 3.38 | 33 / 1335 | 0% | 0 | 0 / 0 |
| heart | 2% | 2.24 | 16 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 1% | 1.04 | 1 / 80 |
| muscle | 1% | 0.66 | 7 / 803 | 0% | 0 | 0 / 0 |
| spleen | 1% | 1.32 | 2 / 241 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0071294 | Biological process | cellular response to zinc ion |
| GO_0071276 | Biological process | cellular response to cadmium ion |
| GO_0071280 | Biological process | cellular response to copper ion |
| GO_0010273 | Biological process | detoxification of copper ion |
| GO_0045926 | Biological process | negative regulation of growth |
| GO_0006882 | Biological process | intracellular zinc ion homeostasis |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | MT1H |
| Protein name | Metallothionein Metallothionein-1H (MT-1H) (Metallothionein-0) (MT-0) (Metallothionein-IH) (MT-IH) |
| Synonyms | |
| Description | FUNCTION: Metallothioneins have a high content of cysteine residues that bind various heavy metals; these proteins are transcriptionally regulated by both heavy metals and glucocorticoids. FUNCTION: Metallothioneins have a high content of cysteine residues that bind various heavy metals. . |
| Accessions | ENST00000332374.5 ENST00000569155.1 H3BTC4 P80294 |
